INFORECERCA: Butlletí Informatiu del Servei de Recerca de l'IMIM
Número: 467
22/07/2016
Comentaris i suggeriments
Banner-noves-convocatories-02
Cercador de convocatòries
Projectes
Termini exhaurit
BrightFocus Foundation
BrightFocus Foundation is a nonprofit organization supporting research and providing public education to help eradicate brain and eye diseases, including Alzheimer's disease, macular degeneration, and glaucoma.
 
Termini exhaurit
BrightFocus Foundation
BrightFocus Foundation is a nonprofit organization supporting research and providing public education to help eradicate brain and eye diseases, including Alzheimer's disease, macular degeneration, and glaucoma.
 
Borses de viatge
Termini exhaurit
ESSO - EUROPEAN SOCIETY OF SURGICAL ONCOLOGY
ESSO’s mission is to support its members in advancing the science and practice of surgical oncology for the benefit of cancer patients through a range of activities including education, research and leadership in multidisciplinary care.
The aim of the Training Fellowships is to allow young surgeons to visit a specialist centre outside of their own country,and help them expand their experience and learn new techniques.
 
Termini exhaurit
UICC-GLOBAL CANCER CONTROL
Union for International Cancer Control (UICC) is a membership organisation that exists to help the global health community accelerate the fight against cancer.
Founded in 1933 and based in Geneva, UICC’s growing membership of over 900 organisations across 155 countries, features the world’s major cancer societies, ministries of health, research institutes and patient groups. Together with its members, key partners, the World Health Organization, World Economic Forum and others, UICC is tackling the growing cancer crisis on a global scale.
 
Termini exhaurit
EUROPEAN FOUNDATION FOR THE STUDY OF DIABETES (EFSD)
 
Premis
Termini exhaurit
EMBO - THE EUROPEAN MOLECULAR BIOLOGY ORGANIZATION
The FEBS | EMBO Women in Science Award highlights major contributions by female scientists to life sciences research. Winners of the award are inspiring role models for future generations of women in science. The award is a joint initiative of EMBO and the Federation of European Biochemical Societies (FEBS) .
Each year the exceptional achievements of one woman working in the life sciences in Europe will be rewarded.
 
Termini exhaurit
HOSPITAL SAN RAFAEL DE LA CORUÑA
Premiar el millor treball sobre biomarcadors i medicina personalitzada.
 
Termini exhaurit
THE HERTIE FOUNDATION
The Hertie Foundation is active in the areas of neuroscience, education and social innovation. It is one of the three largest private patrons of brain research in Europe.

The Hertie Foundation, in cooperation with the Federation of European Neuroscience Societies (FENS), established this prize in 2009 in order to recognise outstanding work by young researchers in any field of neuroscience.
 
 
 
Informació últil
 
 No hi ha novetats
 
 
Banner-convocatories-tancament-02
Projectes
Termini exhaurit
FJL - FONDATION JEROME LEJEUNE
The main target of the Fondation Jerome Lejeune, a non profit foundation, is research into genetic diseases with intellectual disability.
 
Termini exhaurit
ALZHEIMER'S DRUG DISCOVERY FOUNDATION
The Alzheimer's Drug Discovery Foundation (ADDF) funds drug discovery and development research programs in the field of Alzheimer's disease (AD), related dementias and cognitive aging. The ADDF seeks to fill the critical translational funding gap between basic research and later stage drug development by funding promising drug discovery and development programs. In addition to funding academic programs, the ADDF also invests in and creates early stage biotechnology companies. The ADDF also co-sponsors conferences to stimulate new ideas and approaches in areas of interest to the Foundation.
 
Premis
Termini exhaurit
AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR)
The award is given to an individual whose leadership and extraordinary achievements in cancer research or in support of cancer research have made a major impact on the field. Such achievements include contributions to the acceleration of progress in cancer research, raising national or international awareness of cancer research, or other demonstrations of a sustained commitment to the conquest of cancer.
 
Termini exhaurit
AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR)
This lectureship will recognize an individual scientist whose novel and significant work has had or may have a far-reaching impact on the detection, diagnosis, treatment, or prevention of cancer.
 
Termini exhaurit
AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR)
The AACR and the American Cancer Society established this award in 1992 to honor outstanding research accomplishments in the fields of cancer epidemiology, biomarkers, and prevention.
 
Termini exhaurit
AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR)
The prestigious Pezcoller Foundation–AACR International Award for Cancer Research was established in 1997 to annually recognize a scientist of international renown:
  • who has made a major scientific discovery in basic cancer research OR who has made significant contributions to translational cancer research;
  • who continues to be active in cancer research and has a record of recent, noteworthy publications; and
  • whose ongoing work holds promise for continued substantive contributions to progress in the field of cancer.
    The award is intended to honor an individual scientist. However, more than one scientist may be co-nominated and selected to share the award when their investigations are closely related in subject matter and have resulted in work that is worthy of the award.
    		•
     
    Termini exhaurit
    COMISSIO EUROPEA
    The Horizon Prize for better use of antibiotics is a €1 million prize that will be awarded to the person or team who can most effectively meet the following challenge: develop a rapid test that will allow healthcare providers to distinguish, at the point of care, between patients with upper respiratory tract infections that require antibiotics and those that can be treated safely without antibiotics. In this context "Upper Respiratory Tract Infections" include pharyngitis, sinusitis, otitis as well as bronchitis.
     
    Recursos Humans
    Termini exhaurit
    EMBO - THE EUROPEAN MOLECULAR BIOLOGY ORGANIZATION
    The EMBO Long-Term Fellowships support post-doctoral research visits to laboratories throughout Europe and the world. International exchange is a key feature in the application process.
     
    Termini exhaurit
    HUMAN FRONTIER SCIENCE PROGRAMME

    The Human Frontier Science Program Organization (HFSPO) supports innovative basic research into fundamental biological problems, with emphasis placed on novel approaches that cross disciplinary boundaries.

    Long-Term Fellowships (LTF) are for applicants with a Ph.D. in a biological discipline, who will broaden their expertise by proposing a project in the life sciences which is significantly different from their previous Ph.D. or postdoctoral work.

    Cross-Disciplinary Fellowships (CDF) are for applicants with a Ph.D. from outside the life sciences (e.g. in physics, chemistry, mathematics, engineering or computer sciences), who have not worked in biological fields during their previous training.

    The HFSP fellowship program funds innovative, ground-breaking projects that have the potential to advance knowledge in the applicants’ field of study or open a new approach to a research problem. High risk research is supported.
     
     
     
     
    Articles
     
     
    Núñez J*, García-Blas S, Comín-Colet J. Iron deficiency and risk of early readmission following hospitalization for acute heart failure. Reply. Eur. J. Heart Fail. 2016; 18(7): 881.
     
    Costas Caudet L*, Benavente Moreno Y, Olmedo Requena R, Casabonne D, Robles C, Gonzalez-Barca EM, De la Banda E, Alonso E, Aymerich M, Tardón A, Marcos-Gragera R, Gimeno E, Gómez Acebo I, Papantoniou K, Castaño Vinyals G, Aragonés Sanz N, Pollán M, Kogevinas M, de Sanjosé S. Night shift work and chronic lymphocytic leukemia in the MCC-spain case-control study. Int J Cancer 2016; 139(9): 1994-2000.
     
    Mariotti M, Lobanov AV, Manta B, Santesmasses D, Bofill A, Guigó R, Gabaldón T, Gladyshev VN*. Lokiarchaeota Marks the Transition between the Archaeal and Eukaryotic Selenocysteine Encoding Systems. Mol Biol Evol 2016; 33(9): 2441-2453.
     
    Cabrera S, Vallès E*, Benito B, Alcalde O, Jiménez-López J, Fan R, Martí Almor J. Simple predictors for new onset atrial fibrillation. Int J Cardiol 2016; 221: 515-520.
     
    Prats Sánchez L*, Camps Renom P, Sotoca-Fernández J, Delgado Mederos R, Martínez-Domeño A, Marin R, Almendrote M, Dorado L, Gomis M, Codas J, Llull L, Gómez-González A, Roquer-González J, Purroy F, Gómez-Choco M, Cánovas D, Cocho D, Garcés M, Abilleira S, Martí Fàbregas J, on behalf of the Catalan Stroke Code and Reperfusion Consortium (Cat-SCR). Remote Intracerebral Hemorrhage After Intravenous Thrombolysis: Results From a Multicenter Study. Stroke 2016; 47(8): 2003-2009.
     
    Grau S*, Luque S, Echeverría-Esnal D, Sorli L, Campillo N, Montero MM, Álvarez-Lerma F, Plasencia V, Horcajada JP. Urinary micafungin levels are sufficient to treat urinary tract infections caused by Candida spp. Int J Antimicrob Ag 2016; 48(2): 212-214.
     
    Faherty SL*, Villanueva-Cañas JL, Klopfer PH, Albà MM, Yoder AD. Gene expression profiling in the hibernating primate, Cheirogaleus medius. Genome Biol Evol 2016; 8(8): 2413-2426.
     
    Ríos A*, López-Navas AI, López-López AI, Gómez FJ, Iriarte J, Herruzo R, Blanco G, Llorca FJ, Asunsolo A, Sánchez-Gallegos P, Gutiérrez PR, Fernández A, de Jesús MT, Martínez-Alarcón L, Lana A, Fuentes L, Hernández JR, Virseda J, Yelamos J, Bondía JA, Hernández AM, Ayala MA, Ramírez P, Parrilla P. Acceptance of living liver donation among medical students: A multicenter stratified study from Spain. World J Gastroenterol 2016; 22(25): 5800-5813.
     
    Marcelino-Rodríguez I, Oliva-García J, Alemán-Sánchez JJ, Almeida-González D, Dominguez-Coello S, Brito-Diaz B, Gannar F, Rodríguez-Pérez MC, Elosua R, Cabrera de León A*. Lipid and inflammatory biomarker profiles in early insulin resistance. Acta Diabetol 2016; 53(6): 905-913.
     
    Colomer R*, Pascual T, Albanell J. Is Metastatic Disease the Best Setting for Cost-Effectiveness Studies?. J Clin Oncol 2016; 34(26): 3226-3227.
     
    Santín M, García-García JM, Rigau D, Altet N, Anibarro L, Casas I, Díez N, García-Gasalla M, Martínez-Lacasa X, Penas A, Pérez-Escolano E, Sánchez F, Domínguez J*, Grupo de expertos del Grupo de Estudio de Micobacterias (GEIM) de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC) y la Sociedad Española de Enfermedades Respiratorias y Cirugía torácica (SEPAR). Sumario ejecutivo de la guía de práctica clínica sobre el uso de las pruebas de liberación de interferón-gamma para el diagnóstico de infección tuberculosa. Arch Bronconeumol 2016; 52(9): 477-481.
     
    Sanchis J*, Núñez E, Barrabés JA, Marín F, Consuegra-Sánchez L, Ventura S, Valero E, Roqué M, Bayés-Genís A, García-del Blanco B, Dégano IR, Núñez J. Randomized comparison between the invasive and conservative strategies in comorbid elderly patients with non-ST elevation myocardial infarction. Eur J Intern Med 2016; 35: 89-94.
     
    Roncero C*, Barral C, Rodríguez-Cintas L, Pérez-Pazos J, Martínez-Luna N, Casas M, Torrens M, Grau-López L. Psychiatric comorbidities in opioid-dependent patients undergoing a replacement therapy programme in Spain: The PROTEUS study. Psychiat Res 2016; 243: 174-181.
     
    Cobo J*, Nieto L, Ochoa S, Pousa E, Usall J, Baños I, González B, Ruiz I, Ruiz-Ripoll I, Insight Barcelona Research Group (...,Molins-Galvez F,...). Insight and gender in schizophrenia and other psychoses. Psychiat Res 2016; 243: 268-277.
     
    Angona A, Álvarez-Larran A*, Bellosillo B, Longarón R, Camacho L, Fernández-Rodríguez MC, Pairet S, Besses C. Characterization of CD34+ hematopoietic progenitor cells in JAK2V617F and CALR-mutated myeloproliferative neoplasms. Leuk Res 2016; 48: 11-15.
     
    Navalpotro-Gómez I*, Vivanco R, Cuadrado E, Medrano-Martorell S, Alameda F, Villalba G, Roquer-González J. Focal status epilepticus as a manifestation of idiopathic hypertrophic cranial pachymeningitis. J Neurol Sci 2016; 367: 232-236.
     
     
     
     
    Institut Hospital del Mar d'Investigacions Mèdiques
    Tel: 93 316 04 00
    Doctor Aiguader, 88
    08003 Barcelona
    Seguiu-nos a:
    Twitter
    Youtube
    En compliment de la Llei 34/2002, de Serveis de la Societat de la Informació i de Comerç Electrònic, aquest correu li hem enviat a partir de les dades de contacte que vostè ens ha facilitat. Si vostè no desitja rebre més comunicats, pot donar-se de baixa dirigint-se per escrit al Servei de Recursos Humans-IMIM (RRHHconfidencialitat@imim.es) tot indicant la paraula “baixa base de dades” a l’assumpte.
    Li recordem que podrà exercir els drets d’accés, rectificació, cancel·lació i oposició dirigint-se per escrit al Servei de Recursos Humans-IMIM (RRHHconfidencialitat@imim.es).